Will Sanofi's Lantus Survive Cancer Scare? Studies Suggest a Worrisome Link
This article was originally published in The Pink Sheet Daily
Executive Summary
But the data also suggest a higher cancer risk could be due to "patient characteristics," and not Lantus itself.